Latest News: Conference Dates: 11th-13thApril, 2018 All the registered authors have to send the final PPT to before 11th April 2018 Acceptance Notification Starts From: 15-03-2018 Camera Ready Paper Submission: 25-03-2018 - (Extended to)31-03-2018 Early Registration Ends On: 25-03-2018 -(Extended to)31-03-2018 Late Registration Ends On: 02-04-2018

Invited Talk-II-Biomedical Engineering

“Cancer Theranostics: Role of organo-inorganic hybrid nanosystems”


Cancer Theranostics is undergoing tremendous upgradation and refinement especially in terms of increased specificity in killing cancer cells and reduced toxicity to normal cells. Nanomedicine is serving to be an important tool in the arena of cancer drug delivery, gaining special interest in the recent past owing to the development of commercialized formulations like Abraxane and Doxil, that could potentially alter the current cancer treatment strategy. Our work involves development of organo inorganic hybrid nanostructures for Photothermal Therapy, Imaging, Controlled/Triggered drug delivery. We are also working on combinative treatment strategy (Thermochemotherapy) that involves biodegradable drug carrier (eg Liposomes, Polymers like PLGA , PCL etc) combined with NIR dye/Au nanoparticles which in addition to performing drug delivery to cancer site, could as well kill cancer cells through hyperthermia.


Dr. Aravind Kumar Rengan is currently an Assistant Professor at IIT Hyderabad. He had a successful start in academics, obtaining merit seat for his M.B.B.S at Thanjavur Govt. Medical College (Tamilnadu Dr.M.G.R Medical University). During his medical internship, he was captivated by research in the emerging field of nanoscience and technology. This made him to take up Master in Nano-medical sciences at Amrita Centre for Nanosciences and Molecular medicine-DST Centre of Excellence. Owing to his competitive academic performance he was able to secure University rank and Department of Science and Technology (DST) fellowship. Immediately after his masters in nanomedical sciences he was selected for his PhD at IIT Bombay. Dr. Aravind is an aggressive learner of nanomedicine and its practical application in biomedical research. His research work was published in prestigious journals like NANOSCALE and ACS NANO LETTERS. Dr. Aravind was instrumental in getting the “The Bill and Melinda Gates” project on “Transdermal TB drug delivery – TB NANODOTS” during his PhD tenure. Dr. Aravind has won many awards and accolades including the “Indian National Science Academy – young scientist 2017” “Innovative Young Biotechnologist Award – DBT. Govt of India”, “Gandhian Young Technological Innovator 2015 & 2017” and “DST Inspire Faculty Award”.